SCHEMBL21453066

SCHEMBL21453066

Fc1cc(-c2cc(NC3CCCC3)ccn2)ccc1OC(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ FAAH O00519 1/20 0.40
▸ GABBR2 O75899 1/20 0.38
▸ GABBR1 Q9UBS5 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ EPHX2 P34913 3/20 0.37
▸ ABL1 P00519 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ TRPA1 O75762 2/20 0.35
▸ TRPV4 Q9HBA0 1/20 0.35
▸ GRM2 Q14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452788 0.99 KDM4E (0.40) KDM4EALDH1A1LMNACYP1A2CYP3A4
SCHEMBL21452943 0.86 FAAH (0.38) FAAHSYKEPHX2ABL1KDR
SCHEMBL21452614 0.86 EPHX2 (0.43) CYP3A4FAAHEPHX2ABL1KDR
SCHEMBL21452672 0.86 EPHX2 (0.43) CYP3A4FAAHEPHX2ABL1KDR
SCHEMBL21433996 0.86 EPHX2 (0.43) CYP3A4FAAHEPHX2ABL1KDR
SCHEMBL21433986 0.85 CDK9 (0.42) CYP3A4FAAHEPHX2KDRTRPA1
SCHEMBL21452730 0.85 CDK9 (0.42) CYP3A4FAAHEPHX2KDRTRPA1
SCHEMBL21434007 0.85 CDK9 (0.42) CYP3A4FAAHEPHX2KDRTRPA1
SCHEMBL21433984 0.85 CDK9 (0.42) CYP3A4FAAHEPHX2KDRTRPA1
SCHEMBL21452942 0.84 EPHX2 (0.48) MAPTSYKEPHX2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback